Need to know how antibodies fit in for a COVID-19 therapy

Great Post from Derek Lowe at Science Translational Medicine. Find out why monoclonal Abs are good but difficult and they may very well be worth pursuit for a long-term strategy as experts are predicting COVID-19 will stay with us for years.​